catechin has been researched along with gadolinium dtpa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andre, F; aus dem Siepen, F; Buss, SJ; Giannitsis, E; Katus, HA; Kristen, AV; Seitz, S; Steen, H | 1 |
| Hu, D; Jiang, X; Li, J; Li, Z; Luo, Y; Shang, L; Shen, Y; Yang, C; Zhang, Z | 1 |
1 trial(s) available for catechin and gadolinium dtpa
| Article | Year |
|---|---|
Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
Topics: Administration, Oral; Aged; Amyloid; Amyloidosis; Camellia sinensis; Capsules; Cardiomyopathies; Catechin; Contrast Media; Extracellular Matrix; Fibrosis; Gadolinium DTPA; Germany; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Myocardium; Plant Extracts; Predictive Value of Tests; Time Factors; Treatment Outcome; Ventricular Remodeling | 2015 |
1 other study(ies) available for catechin and gadolinium dtpa
| Article | Year |
|---|---|
L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent.
Topics: Animals; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Contrast Media; Gadolinium DTPA; Hydrogen-Ion Concentration; Liver Neoplasms; Magnetic Resonance Imaging; Manganese; Mice; Nanoparticles; Peritoneal Neoplasms; Proof of Concept Study | 2021 |